Global Emerging Infectious Disease Market Research Report 2025(Status and Outlook)

March 2025 | 222 pages | ID: G7F4F9853528EN
Bosson Research

Abstracts

Report Overview

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.

This report provides a deep insight into the global Emerging Infectious Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Emerging Infectious Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Emerging Infectious Disease market in any manner.

Global Emerging Infectious Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BD

Abbott

Roche Diagnostics

Merck & Co.

Inc.

GlaxoSmithKline plc

BioMerieux

Danaher

Orasure

Qiagen

Quidel

Sysmex

Gen-Probe

Cepheid

Hologic

Market Segmentation (by Type)

AIDS

Ebola

SARS

Avian Flu

Chikungunya

Zika

Others

Market Segmentation (by Application)

Clinical Laboratories

Diagnostic Centers

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Emerging Infectious Disease Market
• Overview of the regional outlook of the Emerging Infectious Disease Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Emerging Infectious Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Emerging Infectious Disease
1.2 Key Market Segments
1.2.1 Emerging Infectious Disease Segment by Type
1.2.2 Emerging Infectious Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Emerging Infectious Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Emerging Infectious Disease Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Emerging Infectious Disease Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Emerging Infectious Disease Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Emerging Infectious Disease Product Life Cycle
3.3 Global Emerging Infectious Disease Sales by Manufacturers (2020-2025)
3.4 Global Emerging Infectious Disease Revenue Market Share by Manufacturers (2020-2025)
3.5 Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Emerging Infectious Disease Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Emerging Infectious Disease Manufacturing Sites, Area Served, Product Type
3.8 Emerging Infectious Disease Market Competitive Situation and Trends
3.8.1 Emerging Infectious Disease Market Concentration Rate
3.8.2 Global 5 and 10 Largest Emerging Infectious Disease Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Emerging Infectious Disease Industry Chain Analysis
4.1 Emerging Infectious Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Emerging Infectious Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Emerging Infectious Disease Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Emerging Infectious Disease Market
5.7 ESG Ratings of Leading Companies
6 Global Emerging Infectious Disease Market Sales by Region
6.1 Global Emerging Infectious Disease Sales by Region
6.1.1 Global Emerging Infectious Disease Sales by Region
6.1.2 Global Emerging Infectious Disease Sales Market Share by Region
6.2 Global Emerging Infectious Disease Market Size by Region
6.2.1 Global Emerging Infectious Disease Market Size by Region
6.2.2 Global Emerging Infectious Disease Market Size Market Share by Region
7 North America Market Overview
7.1 North America Emerging Infectious Disease Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Emerging Infectious Disease Market Size by Type
7.3 North America Emerging Infectious Disease Market Size by Application
8 Europe Market Overview
8.1 Europe Emerging Infectious Disease Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Emerging Infectious Disease Market Size by Type
8.3 Europe Emerging Infectious Disease Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Emerging Infectious Disease Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Emerging Infectious Disease Market Size by Type
9.3 Asia-Pacific Emerging Infectious Disease Market Size by Application
10 South America Market Overview
10.1 South America Emerging Infectious Disease Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Emerging Infectious Disease Market Size by Type
10.3 South America Emerging Infectious Disease Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Emerging Infectious Disease Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Emerging Infectious Disease Market Size by Type
11.3 Middle East and Africa Emerging Infectious Disease Market Size by Application
12 Emerging Infectious Disease Market Production by Region
12.1 Global Production of Emerging Infectious Disease by Region(2020-2025)
12.2 Global Emerging Infectious Disease Revenue Market Share by Region (2020-2025)
12.3 Global Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Emerging Infectious Disease Production
12.4.1 North America Emerging Infectious Disease Production Growth Rate (2020-2025)
12.4.2 North America Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Emerging Infectious Disease Production
12.5.1 Europe Emerging Infectious Disease Production Growth Rate (2020-2025)
12.5.2 Europe Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Emerging Infectious Disease Production (2020-2025)
12.6.1 Japan Emerging Infectious Disease Production Growth Rate (2020-2025)
12.6.2 Japan Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Emerging Infectious Disease Production (2020-2025)
12.7.1 China Emerging Infectious Disease Production Growth Rate (2020-2025)
12.7.2 China Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2020-2025)
13 Emerging Infectious Disease Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Emerging Infectious Disease Sales Market Share by Type (2020-2033)
13.3 Global Emerging Infectious Disease Market Size Market Share by Type (2020-2033)
13.4 Global Emerging Infectious Disease Price by Type (2020-2033)
14 Emerging Infectious Disease Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Emerging Infectious Disease Market Sales by Application (2020-2033)
14.3 Global Emerging Infectious Disease Market Size (M USD) by Application (2020-2033)
14.4 Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 BD
15.1.1 BD Basic Information
15.1.2 BD Emerging Infectious Disease Product Overview
15.1.3 BD Emerging Infectious Disease Product Market Performance
15.1.4 BD Business Overview
15.1.5 BD SWOT Analysis
15.1.6 BD Recent Developments
15.2 Abbott
15.2.1 Abbott Basic Information
15.2.2 Abbott Emerging Infectious Disease Product Overview
15.2.3 Abbott Emerging Infectious Disease Product Market Performance
15.2.4 Abbott Business Overview
15.2.5 Abbott SWOT Analysis
15.2.6 Abbott Recent Developments
15.3 Roche Diagnostics
15.3.1 Roche Diagnostics Basic Information
15.3.2 Roche Diagnostics Emerging Infectious Disease Product Overview
15.3.3 Roche Diagnostics Emerging Infectious Disease Product Market Performance
15.3.4 Roche Diagnostics Business Overview
15.3.5 Roche Diagnostics SWOT Analysis
15.3.6 Roche Diagnostics Recent Developments
15.4 Merck and Co.
15.4.1 Merck and Co. Basic Information
15.4.2 Merck and Co. Emerging Infectious Disease Product Overview
15.4.3 Merck and Co. Emerging Infectious Disease Product Market Performance
15.4.4 Merck and Co. Business Overview
15.4.5 Merck and Co. Recent Developments
15.5 Inc.
15.5.1 Inc. Basic Information
15.5.2 Inc. Emerging Infectious Disease Product Overview
15.5.3 Inc. Emerging Infectious Disease Product Market Performance
15.5.4 Inc. Business Overview
15.5.5 Inc. Recent Developments
15.6 GlaxoSmithKline plc
15.6.1 GlaxoSmithKline plc Basic Information
15.6.2 GlaxoSmithKline plc Emerging Infectious Disease Product Overview
15.6.3 GlaxoSmithKline plc Emerging Infectious Disease Product Market Performance
15.6.4 GlaxoSmithKline plc Business Overview
15.6.5 GlaxoSmithKline plc Recent Developments
15.7 BioMerieux
15.7.1 BioMerieux Basic Information
15.7.2 BioMerieux Emerging Infectious Disease Product Overview
15.7.3 BioMerieux Emerging Infectious Disease Product Market Performance
15.7.4 BioMerieux Business Overview
15.7.5 BioMerieux Recent Developments
15.8 Danaher
15.8.1 Danaher Basic Information
15.8.2 Danaher Emerging Infectious Disease Product Overview
15.8.3 Danaher Emerging Infectious Disease Product Market Performance
15.8.4 Danaher Business Overview
15.8.5 Danaher Recent Developments
15.9 Orasure
15.9.1 Orasure Basic Information
15.9.2 Orasure Emerging Infectious Disease Product Overview
15.9.3 Orasure Emerging Infectious Disease Product Market Performance
15.9.4 Orasure Business Overview
15.9.5 Orasure Recent Developments
15.10 Qiagen
15.10.1 Qiagen Basic Information
15.10.2 Qiagen Emerging Infectious Disease Product Overview
15.10.3 Qiagen Emerging Infectious Disease Product Market Performance
15.10.4 Qiagen Business Overview
15.10.5 Qiagen Recent Developments
15.11 Quidel
15.11.1 Quidel Basic Information
15.11.2 Quidel Emerging Infectious Disease Product Overview
15.11.3 Quidel Emerging Infectious Disease Product Market Performance
15.11.4 Quidel Business Overview
15.11.5 Quidel Recent Developments
15.12 Sysmex
15.12.1 Sysmex Basic Information
15.12.2 Sysmex Emerging Infectious Disease Product Overview
15.12.3 Sysmex Emerging Infectious Disease Product Market Performance
15.12.4 Sysmex Business Overview
15.12.5 Sysmex Recent Developments
15.13 Gen-Probe
15.13.1 Gen-Probe Basic Information
15.13.2 Gen-Probe Emerging Infectious Disease Product Overview
15.13.3 Gen-Probe Emerging Infectious Disease Product Market Performance
15.13.4 Gen-Probe Business Overview
15.13.5 Gen-Probe Recent Developments
15.14 Cepheid
15.14.1 Cepheid Basic Information
15.14.2 Cepheid Emerging Infectious Disease Product Overview
15.14.3 Cepheid Emerging Infectious Disease Product Market Performance
15.14.4 Cepheid Business Overview
15.14.5 Cepheid Recent Developments
15.15 Hologic
15.15.1 Hologic Basic Information
15.15.2 Hologic Emerging Infectious Disease Product Overview
15.15.3 Hologic Emerging Infectious Disease Product Market Performance
15.15.4 Hologic Business Overview
15.15.5 Hologic Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Emerging Infectious Disease Market Size Comparison by Region (M USD)
Table 5. Global Emerging Infectious Disease Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Emerging Infectious Disease Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Emerging Infectious Disease Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Emerging Infectious Disease Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Infectious Disease as of 2024)
Table 10. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Emerging Infectious Disease Manufacturing Sites and Area Served
Table 12. Manufacturers Emerging Infectious Disease Product Type
Table 13. Global Emerging Infectious Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Emerging Infectious Disease Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Emerging Infectious Disease Sales by Region (2020-2025) & (K Units)
Table 25. Global Emerging Infectious Disease Sales Market Share by Region (2020-2025)
Table 26. Global Emerging Infectious Disease Market Size by Region (2020-2025) & (M USD)
Table 27. Global Emerging Infectious Disease Market Size Market Share by Region (2020-2025)
Table 28. North America Emerging Infectious Disease Market Size by Country (2020-2033) & (M USD)
Table 29. North America Emerging Infectious Disease Sales by Country (2020-2033) & (K Units)
Table 30. North America Emerging Infectious Disease Sales by Type (K Units)
Table 31. North America Emerging Infectious Disease Market Size by Type (M USD)
Table 32. North America Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 33. North America Emerging Infectious Disease Market Size (M USD) by Type (2020-2033)
Table 34. North America Emerging Infectious Disease Sales by Application (K Units)
Table 35. North America Emerging Infectious Disease Market Size by Application (M USD)
Table 36. North America Emerging Infectious Disease Sales (K Units) by Application (2020-2033)
Table 37. North America Emerging Infectious Disease Market Size (M USD) by Application (2020-2033)
Table 38. Europe Emerging Infectious Disease Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Emerging Infectious Disease Sales by Country (2020-2033) & (K Units)
Table 40. Europe Emerging Infectious Disease Sales by Type (K Units)
Table 41. Europe Emerging Infectious Disease Market Size by Type (M USD)
Table 42. Europe Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 43. Europe Emerging Infectious Disease Market Size (M USD) by Type (2020-2033)
Table 44. Europe Emerging Infectious Disease Sales by Application (K Units)
Table 45. Europe Emerging Infectious Disease Market Size by Application (M USD)
Table 46. Europe Emerging Infectious Disease Sales (K Units) by Application (2020-2033)
Table 47. Europe Emerging Infectious Disease Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Emerging Infectious Disease Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Emerging Infectious Disease Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Emerging Infectious Disease Sales by Type (K Units)
Table 51. Asia-Pacific Emerging Infectious Disease Market Size by Type (M USD)
Table 52. Asia-Pacific Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Emerging Infectious Disease Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Emerging Infectious Disease Sales by Application (K Units)
Table 55. Asia-Pacific Emerging Infectious Disease Market Size by Application (M USD)
Table 56. Asia-Pacific Emerging Infectious Disease Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Emerging Infectious Disease Market Size (M USD) by Application (2020-2025)
Table 58. South America Emerging Infectious Disease Market Size by Country (2020-2033) & (M USD)
Table 59. South America Emerging Infectious Disease Sales by Country (2020-2033) & (K Units)
Table 60. South America Emerging Infectious Disease Sales by Type (K Units)
Table 61. South America Emerging Infectious Disease Market Size by Type (M USD)
Table 62. South America Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 63. South America Emerging Infectious Disease Market Size (M USD) by Type (2020-2033)
Table 64. South America Emerging Infectious Disease Sales by Application (K Units)
Table 65. South America Emerging Infectious Disease Market Size by Application (M USD)
Table 66. South America Emerging Infectious Disease Sales (K Units) by Application (2020-2033)
Table 67. South America Emerging Infectious Disease Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Emerging Infectious Disease Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Emerging Infectious Disease Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Emerging Infectious Disease Sales by Type (K Units)
Table 71. Middle East and Africa Emerging Infectious Disease Market Size by Type (M USD)
Table 72. Middle East and Africa Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Emerging Infectious Disease Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Emerging Infectious Disease Sales by Application (K Units)
Table 75. Middle East and Africa Emerging Infectious Disease Market Size by Application (M USD)
Table 76. Middle East and Africa Emerging Infectious Disease Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Emerging Infectious Disease Market Size (M USD) by Application (2020-2033)
Table 78. Global Emerging Infectious Disease Production (K Units) by Region(2020-2025)
Table 79. Global Emerging Infectious Disease Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Emerging Infectious Disease Revenue Market Share by Region (2020-2025)
Table 81. Global Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Emerging Infectious Disease Sales by Type (K Units)
Table 87. Global Emerging Infectious Disease Market Size by Type (M USD)
Table 88. Global Emerging Infectious Disease Sales (K Units) by Type (2020-2033)
Table 89. Global Emerging Infectious Disease Sales Market Share by Type (2020-2033)
Table 90. Global Emerging Infectious Disease Market Size (M USD) by Type (2020-2033)
Table 91. Global Emerging Infectious Disease Market Size Share by Type (2020-2033)
Table 92. Global Emerging Infectious Disease Sales (K Units) by Application
Table 93. Global Emerging Infectious Disease Market Size by Application(M USD)
Table 94. Global Emerging Infectious Disease Sales by Application (2020-2033) & (K Units)
Table 95. Global Emerging Infectious Disease Sales Market Share by Application (2020-2033)
Table 96. Global Emerging Infectious Disease Market Size by Application (2020-2033) & (M USD)
Table 97. Global Emerging Infectious Disease Market Share by Application (2020-2033)
Table 98. Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2033)
Table 99. BD Basic Information
Table 100. BD Emerging Infectious Disease Product Overview
Table 101. BD Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. BD Business Overview
Table 103. BD SWOT Analysis
Table 104. BD Recent Developments
Table 105. Abbott Basic Information
Table 106. Abbott Emerging Infectious Disease Product Overview
Table 107. Abbott Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Abbott Business Overview
Table 109. Abbott SWOT Analysis
Table 110. Abbott Recent Developments
Table 111. Roche Diagnostics Basic Information
Table 112. Roche Diagnostics Emerging Infectious Disease Product Overview
Table 113. Roche Diagnostics Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Roche Diagnostics Business Overview
Table 115. Roche Diagnostics SWOT Analysis
Table 116. Roche Diagnostics Recent Developments
Table 117. Merck and Co. Basic Information
Table 118. Merck and Co. Emerging Infectious Disease Product Overview
Table 119. Merck and Co. Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Merck and Co. Business Overview
Table 121. Merck and Co. Recent Developments
Table 122. Inc. Basic Information
Table 123. Inc. Emerging Infectious Disease Product Overview
Table 124. Inc. Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Inc. Business Overview
Table 126. Inc. Recent Developments
Table 127. GlaxoSmithKline plc Basic Information
Table 128. GlaxoSmithKline plc Emerging Infectious Disease Product Overview
Table 129. GlaxoSmithKline plc Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. GlaxoSmithKline plc Business Overview
Table 131. GlaxoSmithKline plc Recent Developments
Table 132. BioMerieux Basic Information
Table 133. BioMerieux Emerging Infectious Disease Product Overview
Table 134. BioMerieux Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. BioMerieux Business Overview
Table 136. BioMerieux Recent Developments
Table 137. Danaher Basic Information
Table 138. Danaher Emerging Infectious Disease Product Overview
Table 139. Danaher Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Danaher Business Overview
Table 141. Danaher Recent Developments
Table 142. Orasure Basic Information
Table 143. Orasure Emerging Infectious Disease Product Overview
Table 144. Orasure Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Orasure Business Overview
Table 146. Orasure Recent Developments
Table 147. Qiagen Basic Information
Table 148. Qiagen Emerging Infectious Disease Product Overview
Table 149. Qiagen Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Qiagen Business Overview
Table 151. Qiagen Recent Developments
Table 152. Quidel Basic Information
Table 153. Quidel Emerging Infectious Disease Product Overview
Table 154. Quidel Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Quidel Business Overview
Table 156. Quidel Recent Developments
Table 157. Sysmex Basic Information
Table 158. Sysmex Emerging Infectious Disease Product Overview
Table 159. Sysmex Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Sysmex Business Overview
Table 161. Sysmex Recent Developments
Table 162. Gen-Probe Basic Information
Table 163. Gen-Probe Emerging Infectious Disease Product Overview
Table 164. Gen-Probe Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 165. Gen-Probe Business Overview
Table 166. Gen-Probe Recent Developments
Table 167. Cepheid Basic Information
Table 168. Cepheid Emerging Infectious Disease Product Overview
Table 169. Cepheid Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 170. Cepheid Business Overview
Table 171. Cepheid Recent Developments
Table 172. Hologic Basic Information
Table 173. Hologic Emerging Infectious Disease Product Overview
Table 174. Hologic Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 175. Hologic Business Overview
Table 176. Hologic Recent Developments
List of Figures
Figure 1. Product Picture of Emerging Infectious Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Emerging Infectious Disease Market Size (M USD), 2024-2033
Figure 5. Global Emerging Infectious Disease Market Size (M USD) (2020-2033)
Figure 6. Global Emerging Infectious Disease Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Emerging Infectious Disease Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Emerging Infectious Disease Product Life Cycle
Figure 13. Emerging Infectious Disease Sales Share by Manufacturers in 2024
Figure 14. Global Emerging Infectious Disease Revenue Share by Manufacturers in 2024
Figure 15. Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Emerging Infectious Disease Revenue in 2024
Figure 18. Industry Chain Map of Emerging Infectious Disease
Figure 19. Global Emerging Infectious Disease Market PEST Analysis
Figure 20. Global Emerging Infectious Disease Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Emerging Infectious Disease Sales Market Share by Region (2020-2025)
Figure 26. Global Emerging Infectious Disease Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Emerging Infectious Disease Market Size (M USD) by Country
Figure 31. USA Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Emerging Infectious Disease Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Emerging Infectious Disease Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Emerging Infectious Disease Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Emerging Infectious Disease Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Emerging Infectious Disease Market Size (M USD)by Type
Figure 38. North America Emerging Infectious Disease Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Emerging Infectious Disease Market Size (M USD) by Country
Figure 43. Germany Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Emerging Infectious Disease Market Size (M USD) by Type
Figure 54. Europe Emerging Infectious Disease Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Emerging Infectious Disease Market Size (M USD) by Country
Figure 59. China Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Emerging Infectious Disease Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Emerging Infectious Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Emerging Infectious Disease Market Size (M USD) by Type
Figure 70. Asia-Pacific Emerging Infectious Disease Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Emerging Infectious Disease Market Size (M USD) by Country
Figure 75. Brazil Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Emerging Infectious Disease Market Size (M USD) by Type
Figure 82. South America Emerging Infectious Disease Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Emerging Infectious Disease Market Size (M USD) by Country
Figure 87. Saudi Arabia Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Emerging Infectious Disease Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Emerging Infectious Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Emerging Infectious Disease Market Size (M USD) by Type
Figure 98. Middle East and Africa Emerging Infectious Disease Market Size (M USD) by Application
Figure 99. Global Emerging Infectious Disease Production Market Share by Region (2020-2025)
Figure 100. North America Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 103. China Emerging Infectious Disease Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Emerging Infectious Disease Market Size by Type (M USD)
Figure 106. Sales Market Share of Emerging Infectious Disease by Type (2020-2033)
Figure 107. Sales Market Share of Emerging Infectious Disease by Type in 2024
Figure 108. Market Size Share of Emerging Infectious Disease by Type (2020-2033)
Figure 109. Market Size Share of Emerging Infectious Disease by Type in 2024
Figure 110. Global Emerging Infectious Disease Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Emerging Infectious Disease Market Size by Application(M USD)
Figure 113. Global Emerging Infectious Disease Market Share by Application
Figure 114. Global Emerging Infectious Disease Sales Market Share by Application (2020-2033)
Figure 115. Global Emerging Infectious Disease Sales Market Share by Application in 2024
Figure 116. Global Emerging Infectious Disease Market Share by Application (2020-2033)
Figure 117. Global Emerging Infectious Disease Market Share by Application in 2024
Figure 118. Global Emerging Infectious Disease Sales Growth Rate by Application (2020-2033)